Is a complete NNNN research report available?

No complete published report is available for Anbio Biotechnology (NNNN) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Anbio Biotechnology (NNNN)

NASDAQ: NNNN · USD

$9.90

+0.16 (+1.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first NNNN analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	434.5M
Revenue (ttm)	8.6M
Net income (ttm)	6.4M
EPS (ttm)	$0.15
Shares out	43.9M
P/E (trailing)	67.5x
Volume	17,007

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 8.6M
Net income (ttm): 6.4M
EPS (ttm): $0.15
P/E (trailing): 67.5x
Market cap: 434.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All NNNN indicators

Market & fundamental data

Available fields

187

Groups with data

Currency

USD

Showing 187 of 187 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001982708
Company name	Anbio Biotechnology
Country	Germany
Country code	US
Cusip	G0367B105
Employees	27
Enterprise value	$422.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
Industry PE	64.74
Industry PE Fwd	20.56
IPO Date	2025-02-19
Isin	KYG0367B1059
Last refreshed	2026-07-25
Market cap	$434.5M
Market cap category	Small-Cap
Price	$9.9
Price currency	USD
Rev Per Employee	320,253.48x
Sector	Healthcare
Sector PE	44.87
Sector PE Fwd	23.76
Sic	2835
Symbol	NNNN
Website	https://www.anbiobiotechnology.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.47%
EV Earnings	66x
EV/EBIT	73.27x
EV/EBITDA	73.27x
EV/Sales	48.88x
P/B ratio	14.41x
P/E ratio	67.52x
P/S ratio	50.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	66.7%
EBITDA Margin	66.7%
Gross margin	87.24%
Gross Profit	$7.5M
Gross Profit Growth	28.17%
Gross Profit Growth Q	111.69%
Gross Profit Growth3 Y	-15.64%
Net Income	$6.4M
Net Income Growth	169.87%
Net Income Growth Years	2%
Net Income Growth3 Y	-13.84%
Pretax Margin	74.06%
Profit Margin	74.06%
Profit Per Employee	$237,165
Profitable Years	4
ROA	14.66
ROCE	19.13
ROE	27.05
ROIC	15.23

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-77.63%
EPS Growth	161.3
EPS Growth Years	1
Revenue Growth	5.64x
Revenue Growth Q	73.93x
Revenue Growth Years	2x
Revenue Growth3 Y	-28.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.35
Assets	$30.2M
Cash	$11.9M
Current Assets	$30.2M
Current Liabilities	$87,836
Debt	$0
Debt EBITDA	$0
Equity	$30.2M
Liabilities	$87,836
Long Term Assets	$0
Long Term Liabilities	$0
Net Cash	$11.9M
Net Cash By Market Cap	$2.74
Net Cash Growth	22.85%
Net Debt EBITDA	$-2.06
Net Debt Equity	$-0.39
Tangible Book Value	$30.2M
Tangible Book Value Per Share	$0.69

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	344.3
Net Working Capital	$18.3M
Quick ratio	177.1
Working Capital	$30.2M
Working Capital Turnover	$0.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.26%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-77.61%
200-day SMA	24.77
50-day SMA	18.74
50-day SMA vs 200-day SMA	50under200
All Time High	55.65
All Time High Change	-82.21%
All Time High Date	2025-07-15
All Time Low	5.18
All Time Low Change	91.12%
All Time Low Date	2025-02-19
ATR	1.65
Beta1y	1.78
Beta2y	1.42
Ch YTD	-67.08
High	10.04
High52	54.95
High52 Date	2025-08-18
High52ch	-81.98%
Low	9.6
Low52	8.3
Low52 Date	2026-07-10
Low52ch	19.28%
Ma50ch	-47.17%
Price vs 200-day SMA	-60.04%
RSI	30.58
RSI Monthly	50.26
RSI Weekly	34.56
Sharpe ratio	-0.4x
Sortino ratio	-0.56
Total Return	-3.26%
Tr YTD	-67.08
Tr1m	-36.94%
Tr1w	4.32%
Tr3m	-63.7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$5.8M
Operating Income Growth	189.1
Operating Income Growth Q	344.8
Operating Income Growth3 Y	-17.3
Operating margin	66.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	39,691,200%
Float Percent	90.43%
Shares Institutions	0.18%
Shares Out	43,891,200
Shares Qo Q	1.03%
Shares Yo Y	3.27%
Short Float	0.22%
Short Ratio	1.79
Short Shares	0.2

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	39,747.9x
Bv Per Share	0.69
Ch1m	-36.94
Ch1w	4.32
Ch1y	-77.61
Ch3m	-63.7
Ch6m	-67.13
Change	1.64%
Change From Open	1.54
Close	9.74
Days Gap	0.1
Dollar Volume	168,369.3
Earnings Date	2026-04-07
Earnings Time	amc
EBIT	$5.8M
EBITDA	$5.8M
EPS	$0.15
F Score	4
Financing CF	6,947,450
Fiscal Year End	December
Founded	2,021
Graham Number	1.50552
Graham Upside	-84.79
Investing CF	-4,202,496
Ipr	98
Iprfo	88.21
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-07
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-04-07
Lynch Fair Value	$0.73
Lynch Upside	-92.59
Ma150	24.3
Ma150ch	-59.26%
Ma20	10.92
Ma20ch	-9.35%
Net CF	-3,994,121
Next Earnings Date	2026-10-23
Open	9.75
Optionable	No
Position In Range	68.18
Post Close	9.9
Postmarket Change Percent	-1.92
Postmarket Price	$9.71
Price Date	2026-07-24
Price EBITDA	$75.34
Ptbv Ratio	14.41
Relative Volume	0.43x
Revenue	8,646,844x
Tr6m	-67.13%
Volume	17,007

Anbio Biotechnology (NNNN)

Coverage state: Market snapshot only — no published research

Generate the first NNNN analysis

Price

Financial snapshot

Fair-value bridge

Latest news · NNNN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NNNN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on NNNN

Frequently asked questions